Pulmonary hypertension therapy and COPD: still many questions to be answered

Eur Respir J. 2009 Feb;33(2):449-50; author reply 452-3. doi: 10.1183/09031936.00146108.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bosentan
  • Exercise
  • Humans
  • Hypertension, Pulmonary / complications*
  • Hypertension, Pulmonary / drug therapy*
  • Perfusion
  • Pulmonary Artery / pathology
  • Pulmonary Disease, Chronic Obstructive / complications*
  • Pulmonary Disease, Chronic Obstructive / pathology
  • Randomized Controlled Trials as Topic
  • Research Design
  • Sulfonamides / pharmacology
  • Treatment Outcome
  • Ventricular Dysfunction, Left

Substances

  • Sulfonamides
  • Bosentan